Re-evaluation of l(+)-tartaric acid (E 334), sodium tartrates (E 335), potassium tartrates (E 336), potassium sodium tartrate (E 337) and calcium tartrate (E 354) as food additives.
E 334
E 335
E 336
E 337
E 354
calcium tartrate
potassium tartrate
sodium tartrate
tartaric acid
Journal
EFSA journal. European Food Safety Authority
ISSN: 1831-4732
Titre abrégé: EFSA J
Pays: United States
ID NLM: 101642076
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
entrez:
3
9
2020
pubmed:
3
9
2020
medline:
3
9
2020
Statut:
epublish
Résumé
The EFSA Panel on Food Additives and Flavourings (FAF) provides a scientific opinion on tartaric acid-tartrates (E 334-337, 354) when used as food additives. The Scientific Committee for Food (SCF) in 1990 established an acceptable daily intake (ADI) of 30 mg/kg body weight (bw) per day, for l(+)-tartaric acid and its potassium and sodium salts. The metabolism of l(+)-tartaric acid and its potassium sodium salt was shown to be species dependent, with a greater absorption in rats than in humans. No toxic effects, including nephrotoxicity, were observed in toxicological studies in which the l(+)-form was tested. There was no indication for a genotoxic potential of tartaric acid and its sodium and potassium salts. In a chronic study in rats, no indication for carcinogenicity of monosodium l(+)-tartrate was reported at the highest dose tested (3,100 mg/kg bw per day). The available studies for maternal or developmental toxicity did not report any relevant effects; no studies for reproductive toxicity were available; however, no effects on reproductive organs were observed in the chronic toxicity study. The Panel concluded that the data on systemic availability were robust enough to derive a chemical-specific uncertainty factor instead of the usual default uncertainty factor of 100. A total uncertainty factor of 10 was derived by applying a total interspecies uncertainty factor of 1 instead of 10, based on data showing lower internal exposure in humans compared to rats. The Panel established a group ADI for l(+)-tartaric acid-tartrates (E 334-337 and E 354) of 240 mg/kg bw per day, expressed as tartaric acid, by applying the total uncertainty factor of 10 to the reference point of 3,100 mg sodium tartrate/kg bw per day, approximately to 2,440 mg tartaric acid/kg bw per day. The exposure estimates for the different population groups for the refined non-brand-loyal exposure scenario did not exceed the group ADI of 240 mg/kg bw per day, expressed as tartaric acid. Some recommendations were made by the Panel.
Identifiants
pubmed: 32874248
doi: 10.2903/j.efsa.2020.6030
pii: EFS26030
pmc: PMC7448015
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e06030Informations de copyright
© 2020 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
Références
World Health Organ Tech Rep Ser. 1983;696:1-42
pubmed: 6419473
J Agric Food Chem. 2003 Dec 17;51(26):7820-4
pubmed: 14664552
Mutagenesis. 2010 Jul;25(4):335-41
pubmed: 20194420
Biotechnol Lett. 2014 Nov;36(11):2325-30
pubmed: 25048238
Anal Chem. 2006 Oct 1;78(19):6774-82
pubmed: 17007496
Experientia. 1977 Aug 15;33(8):998-9
pubmed: 891842
EFSA J. 2019 Jun 11;17(6):e05741
pubmed: 32626359
Acta Pathol Microbiol Scand. 1968;74(3):305-10
pubmed: 5721197
EFSA J. 2020 Mar 11;18(3):e06031
pubmed: 32874249
Appl Microbiol Biotechnol. 2006 Jun;71(2):155-63
pubmed: 16217652
Br J Nutr. 2007 Jul;98(1):72-7
pubmed: 17381878
J Chromatogr A. 2001 Oct 12;932(1-2):139-43
pubmed: 11695859
Toxicology. 1977 Oct;8(2):263-74
pubmed: 929631
Comp Med. 2003 Aug;53(4):444-7
pubmed: 14524422
EFSA J. 2020 Mar 11;18(3):e06032
pubmed: 32874250
World J Nephrol. 2017 May 6;6(3):162-167
pubmed: 28540206
EFSA J. 2020 Mar 11;18(3):e06030
pubmed: 32874248
Food Chem Toxicol. 1988 Jun;26(6):487-500
pubmed: 3169648
J Am Pharm Assoc Am Pharm Assoc. 1950 May;39(5):275-6
pubmed: 15421919
Appl Microbiol Biotechnol. 2006 Nov;73(2):421-8
pubmed: 17058077
World Health Organ Tech Rep Ser. 1965;309:1-25
pubmed: 14311467
FEMS Microbiol Rev. 2004 Jun;28(3):377-403
pubmed: 15449609
Sci Rep. 2018 Apr 18;8(1):6225
pubmed: 29670137
Br J Nutr. 2003 Oct;90(4):803-7
pubmed: 13129449
EFSA J. 2020 Mar 11;18(3):e06033
pubmed: 32874251
J Endourol Case Rep. 2017 Dec 01;3(1):192-195
pubmed: 29279874
Biopharm Drug Dispos. 1991 Apr;12(3):207-13
pubmed: 2059671
Acta Crystallogr B. 2009 Jun;65(Pt 3):350-4
pubmed: 19461145
World Health Organ Tech Rep Ser. 1964;281:1-189
pubmed: 14162274
J Biosci Bioeng. 2015 May;119(5):538-42
pubmed: 25468422
J Am Pharm Assoc Am Pharm Assoc. 1957 Oct;46(10):575-8
pubmed: 13491456
EFSA J. 2018 Mar 28;16(3):e05206
pubmed: 32625840
Toxicol Appl Pharmacol. 1963 Mar;5:163-7
pubmed: 13940987
Mutat Res. 1991 Aug;260(4):321-9
pubmed: 1870621
Clin Sci Mol Med. 1978 Mar;54(3):273-81
pubmed: 630803
Food Chem Toxicol. 1984 Aug;22(8):623-36
pubmed: 6381265
Food Sci Biotechnol. 2017 Apr 30;26(2):349-355
pubmed: 30263549
Talanta. 2018 Feb 1;178:15-23
pubmed: 29136806
Urology. 2019 Apr;126:49-53
pubmed: 30654140
Toxicology. 1977 Dec;8(3):333-46
pubmed: 595025
Biotechnol Lett. 2017 Dec;39(12):1859-1863
pubmed: 28875343
Proc Soc Exp Biol Med. 1964 Oct;117:97-100
pubmed: 14219969
J Nutr. 2002 Dec;132(12):3784
pubmed: 12468624
Mutat Res. 2006 Oct 10;609(1):47-59
pubmed: 16857419
J Am Pharm Assoc Am Pharm Assoc. 1947 Jul;36(7):217-9
pubmed: 20252802
Electrophoresis. 2018 Jul;39(13):1597-1605
pubmed: 29635703
Comp Med. 2005 Aug;55(4):354-67
pubmed: 16158911
J Chromatogr. 1990 Jun 15;509(1):283-6
pubmed: 2398128
J Toxicol Pathol. 2015 Apr;28(2):89-97
pubmed: 26028818
World Health Organ Tech Rep Ser. 1974;539:1-40
pubmed: 4205977
Arch Toxicol Suppl. 1978;(1):351-3
pubmed: 277129